Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Brain Neoplasms 1

Interventions

Temozolomide 53 Bevacizumab 45 Radiotherapy 28 Radiosurgery 21 Carboplatin 14 Erlotinib Hydrochloride 11 Radiation 10 pembrolizumab 9 Magnetic Resonance Spectroscopy 9 Etoposide 9 Vorinostat 8 Trastuzumab 8 Irinotecan 8 Sunitinib 7 Sorafenib 7 Radiotherapy, Intensity-Modulated 7 Lomustine 7 Lapatinib 7 Capecitabine 7 dabrafenib 6 Ipilimumab 6 Imatinib Mesylate 6 Cyclophosphamide 6 Sirolimus 5 Hydroxyurea 5 Everolimus 5 Bortezomib 5 temsirolimus 4 cabozantinib 4 binimetinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × Fluoresceins × Clear all

NCT02028325 2016-11-08

Fluorescein

Indiana University

Phase 4 Terminated

136 enrolled 4 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡